Mirum Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Frazier Life Sciences Amends Mirum Pharma Stake
Frazier Life Sciences funds and affiliates updated their beneficial ownership in Mirum Pharmaceuticals, detailing recent share acquisitions and a merger-related stock issuance.
NASDAQ
Frazier Life Sciences Public Fund increased its beneficial ownership in Mirum Pharmaceuticals, Inc. following a merger with Frazier Life Sciences Public Overage Fund.
NASDAQ
Frazier Life Sciences entities and associated individuals have filed an Amendment No. 6 to their Schedule 13D for Mirum Pharmaceuticals, Inc., clarifying beneficial ownership attribution for certain funds.